Literature DB >> 18815435

Chylomicrons promote intestinal absorption of lipopolysaccharides.

Sarbani Ghoshal1, Jassir Witta, Jian Zhong, Willem de Villiers, Erik Eckhardt.   

Abstract

Recent data suggest that dietary fat promotes intestinal absorption of lipopolysaccharides (LPS) from the gut microflora, which might contribute to various inflammatory disorders. The mechanism of fat-induced LPS absorption is unclear, however. Intestinal-epithelial cells can internalize LPS from the apical surface and transport LPS to the Golgi. The Golgi complex also contains newly formed chylomicrons, the lipoproteins that transport dietary long-chain fat through mesenteric lymph and blood. Because LPS has affinity for chylomicrons, we hypothesized that chylomicron formation promotes LPS absorption. In agreement with our hypothesis, we found that CaCo-2 cells released more cell-associated LPS after incubation with oleic-acid (OA), a long-chain fatty acid that induces chylomicron formation, than with butyric acid (BA), a short-chain fatty acid that does not induce chylomicron formation. Moreover, the effect of OA was blocked by the inhibitor of chylomicron formation, Pluronic L-81. We also observed that intragastric triolein (TO) gavage was followed by increased plasma LPS, whereas gavage with tributyrin (TB), or TO plus Pluronic L-81, was not. Most intestinally absorbed LPS was present on chylomicron remnants (CM-R) in the blood. Chylomicron formation also promoted transport of LPS through mesenteric lymph nodes (MLN) and the production of TNFalpha mRNA in the MLN. Together, our data suggest that intestinal epithelial cells may release LPS on chylomicrons from cell-associated pools. Chylomicron-associated LPS may contribute to postprandial inflammatory responses or chronic diet-induced inflammation in chylomicron target tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815435     DOI: 10.1194/jlr.M800156-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  202 in total

1.  High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids.

Authors:  Lotta K Stenman; Reetta Holma; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Amyloid precursor protein expression modulates intestine immune phenotype.

Authors:  Kendra L Puig; Adam J Swigost; Xudong Zhou; Mary Ann Sens; Colin K Combs
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-29       Impact factor: 4.147

3.  Elevated lipopolysaccharide in the colon evokes intestinal inflammation, aggravated in immune modulator-impaired mice.

Authors:  Eunok Im; Franz Martin Riegler; Charalabos Pothoulakis; Sang Hoon Rhee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-21       Impact factor: 4.052

4.  Antibiotics Suppress Activation of Intestinal Mucosal Mast Cells and Reduce Dietary Lipid Absorption in Sprague-Dawley Rats.

Authors:  Hirokazu Sato; Linda S Zhang; Kristina Martinez; Eugene B Chang; Qing Yang; Fei Wang; Philip N Howles; Ryota Hokari; Soichiro Miura; Patrick Tso
Journal:  Gastroenterology       Date:  2016-07-18       Impact factor: 22.682

Review 5.  From obesity through gut microbiota to cardiovascular diseases: a dangerous journey.

Authors:  Paolo Marzullo; Laura Di Renzo; Gabriella Pugliese; Martina De Siena; Luigi Barrea; Giovanna Muscogiuri; Annamaria Colao; Silvia Savastano
Journal:  Int J Obes Suppl       Date:  2020-07-20

Review 6.  Immunologic impact of the intestine in metabolic disease.

Authors:  Daniel A Winer; Shawn Winer; Helen J Dranse; Tony K T Lam
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 7.  Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.

Authors:  Irina A Kirpich; Luis S Marsano; Craig J McClain
Journal:  Clin Biochem       Date:  2015-07-04       Impact factor: 3.281

Review 8.  The gut microbiome as novel cardio-metabolic target: the time has come!

Authors:  Sarah Vinjé; Erik Stroes; Max Nieuwdorp; Stan L Hazen
Journal:  Eur Heart J       Date:  2013-11-11       Impact factor: 29.983

9.  Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism.

Authors:  Elodie Luche; Béatrice Cousin; Lucile Garidou; Matteo Serino; Aurélie Waget; Corinne Barreau; Mireille André; Philippe Valet; Michael Courtney; Louis Casteilla; Rémy Burcelin
Journal:  Mol Metab       Date:  2013-07-04       Impact factor: 7.422

Review 10.  Adaptive immunity in obesity and insulin resistance.

Authors:  Henrike Sell; Christiane Habich; Juergen Eckel
Journal:  Nat Rev Endocrinol       Date:  2012-07-31       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.